EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

2‐Aroyl quinazolinone: Synthesis and in vitro anti‐parasitic activity

Koketso J Setshedi, Richard M Beteck, Omobolanle J Jesumoroti, Kayhan Ilbeigi, Dorien Mabille, Guy Caljon, Frank Van der Kooy, Lesetja J Legoabe iD

Chemical Biology & Drug Design · 2023-10 · 102 (4) · 763-772

DOI: 10.1111/cbdd.14284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 23.06.2023. Verfasst von Koketso J Setshedi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa. Hauptthemen laut MEDLINE: Parasites, Antiprotozoal Agents, Trypanosoma brucei brucei, Trypanosoma cruzi. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trypanosomes and Leishmania are parasitic protozoans that affect millions of people globally. Herein we report the synthesis of 2‐aroyl quinazolinones and their antiprotozoal efficacy against Trypanosoma brucei , Trypanosoma brucei rhodesiense , Trypanosoma cruzi , and Leishmania infantum . These compounds were counter‐screened against a human cell line for cytotoxicity. Thirteen of the twenty target compounds in this study inhibited the growth of these parasites, with compounds KJ1 , and KJ10 exhibiting IC 50 values of 4.7 μM ( T. b. brucei ) and 1.1 μM ( T. b. rhodesiense ), respectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ParasitesAntiprotozoal AgentsTrypanosoma brucei bruceiTrypanosoma cruziLeishmania infantumAnimalsHumansQuinazolinones

Stichwörter der Autor:innen

2-Aroyl quinazolinone derivativesanti-leishmanial activityanti-trypanosomal activityone-pot oxidation

Substanzen

QuinazolinonesAntiprotozoal Agents

Autor:innen und Institutionen

  • Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa.
  • Laboratory of Microbiology, Parasitology and Hygiene, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.

ORCID-Profile: Lesetja J Legoabe

Förderung

  • National Research Foundation

Zitieren

APA

Setshedi, K. J., Beteck, R. M., Jesumoroti, O. J., Ilbeigi, K., Mabille, D., Caljon, G., Van der Kooy, F., & Legoabe, L. J. (2023). 2‐Aroyl quinazolinone: Synthesis and in vitro anti‐parasitic activity. Chemical Biology & Drug Design, 102(4), 763-772. https://doi.org/10.1111/cbdd.14284

Vancouver

Setshedi KJ, Beteck RM, Jesumoroti OJ, Ilbeigi K, Mabille D, Caljon G, et al. 2‐Aroyl quinazolinone: Synthesis and in vitro anti‐parasitic activity. Chemical Biology & Drug Design. 2023;102(4):763-772. doi:10.1111/cbdd.14284

BibTeX
@article{Setshedi2023,
  author = {Setshedi, Koketso J and Beteck, Richard M and Jesumoroti, Omobolanle J and Ilbeigi, Kayhan and Mabille, Dorien and Caljon, Guy and Van der Kooy, Frank and Legoabe, Lesetja J},
  title = {2‐Aroyl quinazolinone: Synthesis and in vitro anti‐parasitic activity},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  volume = {102},
  number = {4},
  pages = {763--772},
  doi = {10.1111/cbdd.14284}
}
Kostenlos starten →